Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
VIHVAC-B: GenHevac-B Vaccination Strategies in HIV-Infected Patients
NCT00480792Phase 3Completed
- Sponsor
- ANRS
- Start
- Jun 2007
- Primary completion
- Dec 2008
- Modality
- Vaccines & Immunotherapeutics
- Countries
- 1
01
Overview
A Phase 3 trial of GenHevac-B in hepatitis B (HBV), sponsored by ANRS. Started Jun 2007; status: completed.
02
Drugs
GenHevac-B
03
Conditions
hepatitis B (HBV)
Beyond the preview
Go deeper on NCT00480792.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00480792.